Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. (Q51007218)
Jump to navigation
Jump to search
scientific article published on 30 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. |
scientific article published on 30 March 2015 |
Statements
1 reference
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. (English)
1 reference
David Porter
1 reference
Anthony R Mato
1 reference
Kenneth A Foon
1 reference
Tatyana Feldman
1 reference
Stephen J Schuster
1 reference
Jakub Svoboda
1 reference
Kar Fai Chow
1 reference
Marisa Valentinetti
1 reference
Mary Mrkulic
1 reference
Kelly Azzollini
1 reference
Gabriella Gadaleta
1 reference
Pritish K Bhattacharyya
1 reference
Joshua Zenreich
1 reference
Lauren-Nicole Pascual
1 reference
Kara Yannotti
1 reference
Sabrina Kdiry
1 reference
Christina Howlett
1 reference
Lauren Strelec
1 reference
Coleen Bejot
1 reference
André Goy
1 reference
30 March 2015
1 reference
90
1 reference
487-492
1 reference
6
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference